Literature DB >> 33585139

A Case of Chronic Eosinophilic Leukemia in a Patient With Recurrent Cough, Dyspnea, and Eosinophilia.

Nino Balanchivadze1, James P Purtell2, Jessica Anderson3, Yue Guo1, Irina Dobrosotskaya4.   

Abstract

We report the case of a 40-year-old man with no significant past medical history who had been hospitalized multiple times over the course of one year with recurring cough, dyspnea, pruritic rash, and variable degrees of eosinophilia. He was variably diagnosed with asthma and pneumonia. After his last hospitalization with severe symptoms, the patient was referred for pulmonary evaluation where hypereosinophilia (HE) led to a hematologic workup. Fluorescence in situ hybridization revealed the FIP1L1-PDGFRA gene fusion and bone marrow analysis confirmed a diagnosis of chronic eosinophilic leukemia. The patient was treated with daily imatinib and prednisone and he was symptom-free at a four-week follow-up examination.
Copyright © 2021, Balanchivadze et al.

Entities:  

Keywords:  chronic eosinophilic leukemia; hypereosinophilia

Year:  2021        PMID: 33585139      PMCID: PMC7872884          DOI: 10.7759/cureus.12654

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  8 in total

1.  Reversal of hypereosinophilic syndrome and lymphomatoid papulosis with mepolizumab and imatinib.

Authors:  Mark J Koury; John H Newman; John J Murray
Journal:  Am J Med       Date:  2003-11       Impact factor: 4.965

2.  Chronic eosinophilic leukaemia revealed by lymphomatoid papulosis: the role of the FIP1-like 1-platelet-derived growth factor receptor alpha fusion gene.

Authors:  C Thuny; C Gaudy-Marqueste; I Nicol; J Gabert; R Costello; J J Grob; M A Richard
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-08-16       Impact factor: 6.166

Review 3.  Evaluation and differential diagnosis of marked, persistent eosinophilia.

Authors:  Rojelio Mejia; Thomas B Nutman
Journal:  Semin Hematol       Date:  2012-04       Impact factor: 3.851

4.  Platelet-derived growth factor receptor-alpha-associated hypereosinophilic syndrome and lymphomatoid papulosis.

Authors:  T McPherson; E W Cowen; E McBurney; A D Klion
Journal:  Br J Dermatol       Date:  2006-10       Impact factor: 9.302

Review 5.  How I treat hypereosinophilic syndromes.

Authors:  Amy D Klion
Journal:  Blood       Date:  2015-05-11       Impact factor: 22.113

6.  Lymphomatoid papulosis associated with both severe hypereosinophilic syndrome and CD30 positive large T-cell lymphoma.

Authors:  B Granel; J Serratrice; L Swiader; N Horshowski; D Blaise; N Vey; D Metras; G Habib; P Disdier; P J Weiller
Journal:  Cancer       Date:  2000-11-15       Impact factor: 6.860

Review 7.  Myeloid neoplasms with eosinophilia.

Authors:  Andreas Reiter; Jason Gotlib
Journal:  Blood       Date:  2016-12-27       Impact factor: 22.113

Review 8.  Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.

Authors:  Ayalew Tefferi; Jason Gotlib; Animesh Pardanani
Journal:  Mayo Clin Proc       Date:  2010-01-06       Impact factor: 7.616

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.